|
Aug 11
|
Cipher Pharmaceuticals Kept at Buy at Stifel Canada Following Q2 Results; Price Target Raised to C$20.00
|
|
Aug 10
|
Cipher Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 7
|
Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue
|
|
Jul 29
|
Cipher Pharmaceuticals Schedules Q2 2025 Earnings Release and Conference Call
|
|
Jun 13
|
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders
|
|
Mar 11
|
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call
|